Specialty products mainly refer to pharmaceuticals for rare diseases for which the number of patients is extremely small, pharmaceuticals that require special handling such as ultra-low temperature transport, and highly anticipated regenerative medicine products. Difficult to incorporate into normal pharmaceutical distribution systems, specialty products require the development of optimal distribution systems and unified handling procedures. Our company was established in June 2013 as a wholesale business company of the Alfresa Group. We will deliver what is needed, when needed to where it is needed, by taking advantage of Japan’s largest ethical pharmaceutical distribution network and our proprietary advanced temperature control distribution technology.
The sequence of events leading up to a patient receiving treatment is referred to as the “patient journey,” and for rare diseases, this becomes a particularly long journey. For patients with rare diseases, there is great significance in receiving a proper diagnosis at an early phase. What we can do to achieve this is to contribute to early disease detection and early adoption of therapeutic drugs, to raise awareness and understanding of rare diseases through disease awareness activities, and to promptly connect this information to distribution.
We believe that these activities lead to the happiness of patients and their families and also the joy of medical professionals.